These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7760978

  • 1. Evidence for differential modulation of mu-opioid receptor-mediated antinociceptive and antitussive activities by spleen-derived factor(s) from diabetic mice.
    Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.
    Neuropharmacology; 1994 Dec; 33(12):1553-8. PubMed ID: 7760978
    [Abstract] [Full Text] [Related]

  • 2. The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.
    Kamei J, Kawashima N, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y.
    Psychopharmacology (Berl); 1993 Dec; 113(2):167-71. PubMed ID: 7855177
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice.
    Kamei J, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y.
    Eur J Pharmacol; 1993 Mar 30; 234(1):117-20. PubMed ID: 8386091
    [Abstract] [Full Text] [Related]

  • 4. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 30; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 5. Modulation of mu-mediated antitussive activity in rats by a delta agonist.
    Kamei J, Tanihara H, Kasuya Y.
    Eur J Pharmacol; 1991 Oct 02; 203(1):153-6. PubMed ID: 1665789
    [Abstract] [Full Text] [Related]

  • 6. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    Mattia A, Vanderah T, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1991 Aug 02; 258(2):583-7. PubMed ID: 1650835
    [Abstract] [Full Text] [Related]

  • 7. Possible involvement of mu 2-mediated mechanisms in mu-mediated antitussive activity in the mouse.
    Kamei J, Iwamoto Y, Kawashima N, Suzuki T, Nagase H, Misawa M, Kasuya Y.
    Neurosci Lett; 1993 Jan 12; 149(2):169-72. PubMed ID: 8386345
    [Abstract] [Full Text] [Related]

  • 8. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y.
    Brain Res; 1992 Feb 07; 571(2):199-203. PubMed ID: 1319265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
    Sofuoglu M, Portoghese PS, Takemori AE.
    Life Sci; 1993 Feb 07; 52(8):769-75. PubMed ID: 8383271
    [Abstract] [Full Text] [Related]

  • 15. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
    Suh HH, Tseng LF.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul 07; 342(1):67-71. PubMed ID: 1976234
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward.
    Duvauchelle CL, Fleming SM, Kornetsky C.
    Eur J Pharmacol; 1996 Dec 05; 316(2-3):137-43. PubMed ID: 8982679
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.